Millennium Management’s Genmab GMAB Stock Holding History

Millennium Management’s Portfolio GMAB Stock Details GMAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-128,100	Closed	-$2.67M	–	6053
2024 Q4	$2.67M	Buy	+128,100	New	+$2.81M	﹤0.01%	3394
2021 Q4	–	Sell	-50,000	Closed	-$2.19M	–	7011
2021 Q3	$2.19M	Buy	+50,000	New	+$2.24M	﹤0.01%	3804

Other funds holding GMAB

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Millennium Management's GMAB Position: Q1 2026 in Review

Millennium Management increased its Genmab (GMAB) stake by 738% in Q1 2026, buying an estimated $20.9M and bringing the position to 792,293 shares worth $21.3M. The position accounts for 0.01% of the portfolio, ranked #1499.

Millennium Management first reported a position in GMAB in Q3 2019 and has held it in 24 quarters since. The position peaked at $39M in Q4 2022. 272 funds tracked by Wall St. Rank hold GMAB as of Q1 2026.

Millennium Management held 792,293 shares of Genmab worth $21.3M as of Q1 2026.
Millennium Management bought 697,720 Genmab shares in Q1 2026, an estimated $20.9M.
Genmab made up 0.01% of Millennium Management's portfolio in Q1 2026, its #1499 holding.
Millennium Management first reported a position in Genmab in Q3 2019 and has held it in 24 quarters since.
Millennium Management's Genmab position peaked at $39M in Q4 2022.
272 funds tracked by Wall St. Rank held Genmab as of Q1 2026.

Based on Millennium Management's 13F filing for Q1 2026, filed 15 May 2026.